American Association for the Study of Liver Disease (AASLD): The Liver Meeting

The Liver Meeting®

The 63rd Annual Meeting of the American Association for the Study of Liver Diseases 2012November 9–13Hynes Convention Center Boston, MassaCHusetts, usa

Program and registration informationSectioN 1: OverviewSectioN 2: Program InformationSectioN 3: Registration and Housing Information

T H e L I v e R M e e T I n g ® 2 0 1 2 • B O S T O n , M A S S A c H u S e T T S , u S A2

taBle of Contents

www.twitter.com/AASLDNewsTweet about the meeting @AASLDnews with our official meeting hashtag #Livermeeting

www.facebook.com/AASLDNews“Like” AASLD on Facebook for photos, videos, and other exclusive meeting content

The Liver Meeting® is mobile. Search sessions and speakers, create your schedule, and read abstracts on the MyItinerary app. The app will be available in October for download in the Apple Store and on AASLD.org.

be Social.

be mobile.

SectioN 1: overview

Message from the President . . . . . . . . . . . . . . . . . . . . 3

Attendee Demographics . . . . . . . . . . . . . . . . . . . . . . . . 4

SectioN 2: ProgrAm iNformAtioN

Meeting-at-a-glance . . . . . . . . . . . . . . . . . . . . . . . . . . . 6

Programming

• Plenary, Parallel, and Poster Sessions, Late-breaking Abstracts . . . . . . . . . . . . . . . . . . . . . . 8

• Session and course Descriptions . . . . . . . . . . . . . 10

continuing Medical education (cMe) . . . . . . . . . . . 19

exhibit Hall . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .20

general Information . . . . . . . . . . . . . . . . . . . . . . . . . . 21

SectioN 3: regiStrAtioN AND HouSiNg

Register Online . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22

Boston Highlights . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22

Registration Fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23

Hotels and Rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24

Additional Registration Information . . . . . . . . . . . . . 25

“The Liver Meeting® is a remarkable event with massive new information which is relevant in daily clinical practice.” — 2011 AtteNDee

T H e L I v e R M e e T I n g ® 2 0 1 2 • B O S T O n , M A S S A c H u S e T T S , u S A 3

RegisteR

Use promo code LM12eb

MeSSAge FROM THe PReSIDenT

On behalf of the American Association for the Study of Liver Diseases (AASLD), it is my great pleasure to invite you to attend the Liver meeting® 2012 — AASLD’s 63rd Annual meeting — to be held

november 9–13 in Boston. This vibrant city is renowned for its cultural facilities and world-class educational institutions, as well as its place at the forefront of American history. While in Boston, you will network with colleagues, exchange the latest trends and best practices, and discuss treatment outcomes with the best and brightest in the field of hepatology.

each year, AASLD develops a comprehensive, yet customizable, program firmly rooted in the most cutting-edge scientific research and the most current recommendations in the practice of hepatology, and this year is no different.

Our Postgraduate course, Personalized Medicine and the Practice of Hepatology, will introduce important advances in the genetic and molecular understanding of liver diseases and their translation into the clinical arena. State-of-the-Art Lectures will address exciting topics such as the role of normal constituents of the intestinal microbiota in disease, controversies in transplant for Hcc, current management of alcoholic hepatitis, and the role of mitochondria in drug-induced liver injury. The President’s choice lecture will focus on the history and progress in the treatment of hepatitis B since 1982 through the eyes of someone involved in this progress.

AASLD also continues to collaborate with the centers for Disease control and Prevention (cDc), the national Institutes of Health (nIH), the International Liver Transplantation Society (ILTS), the American Society for gastrointestinal endoscopy (ASge), and the north American Society for Pediatric gastroenterology, Hepatology and nutrition (nASPgHAn) on a wide range of specialized and cross-disciplinary programming at this year’s meeting.

All in all, it is an extremely diverse program. Whether you are a researcher, educator, practicing clinician, mid-level provider, or in training, we are confident you will find the sessions that are most relevant to you, your patients, and your research.

We look forward to seeing you this fall.

Sincerely,

guadalupe garcia-tsao, mD AASLD President

http://www.aasld.org/lm2012/2012/attendees/Pages/registration.aspx

http://www.aasld.org/lm2012/2012/program/TicketedSessions/Pages/PostGraduateCourse.aspx


attendee Demographics

wHo AtteNDS tHe Liver meetiNg®*

AtteNDee YeArS iN PrActice*

AtteNDee ProfeSSioNAL ActivitieS*

AtteNDee PArticiPAtioN*

fellow/trainee13%

Less than 5 yrs12%

first time28%

Basic research15%midlevel

Provider7%

Physician/ Pediatrics

3%

Physician/Practitioner41%

11–20 yrs20%

every other Year

10%

scientist17%

surgeon3%

not applicable

32%

20+ yrs19%

Varies18%

other7%

industry representative

10%

5–10 yrs17%

every Year44%

Clinical research

25%Patient Care36%

industry rep.11%

other4%

administration3%

education/training7%

goals and objectives:• Provide a forum for the exchange of

groundbreaking basic, translational and clinical research in diseases of the liver and biliary tract and in liver transplantation

• create an arena for the presentation and interchange of opinions on state-of-the art care and management of the full spectrum of patients with liver disease

who should attend?All professionals involved with the study, treatment, and management of liver disease. This includes specialists in adult and pediatric hepatology, gastroenterology, surgery, pathology, anesthesiology, radiology and related basic sciences, as well as primary care physicians, nurses and allied health professionals and trainees in each of these disciplines.

More than 8,500 hepatologists and hepatology health professionals from across the nation and around the world will gather in Boston at The Liver Meeting® 2012 to exchange the latest liver disease research, discuss treatment outcomes, and interact with colleagues at the annual must-attend event in the science and practice of hepatology.


RegisteR


AtteNDeeS bY couNtrY*

Pacific28%

mountain3%

nW Central4%

ne Central9%

midatlantic24%

new england10%

se Central2%

south atlantic15%sW Central

5%

* Source: The Liver Meeting® 2011 registration

uS AtteNDee bY regioN*

CountryTotal Count Per Country

Country Percentage

Algeria 18 0.21%

Argentina 71 0.81%

Armenia 1 0.01%

Australia 178 2.03%

Austria 58 0.66%

Bangladesh 4 0.05%

Belarus 3 0.03%

Belgium 88 1.00%

Bosnia & Herzegovina 1 0.01%

Brazil 147 1.68%

Bulgaria 3 0.03%

Cambodia 4 0.05%

Canada 249 2.84%

Chile 12 0.14%

China 323 3.69%

Colombia 37 0.42%

Croatia 5 0.06%

Cyprus 1 0.01%

Czech Republic 28 0.32%

Denmark 48 0.55%

Dominican Rep 1 0.01%

Egypt 100 1.14%

Estonia 7 0.08%

Finland 16 0.18%

France 283 3.23%

Georgia 19 0.22%

Germany 264 3.01%

Ghana 1 0.01%

Greece 74 0.84%

Greenland 1 0.01%

Guatemala 1 0.01%

Hong Kong 14 0.16%


Country Percentage

Hungary 9 0.10%

Iceland 2 0.02%

India 53 0.60%

Indonesia 7 0.08%

Iran 1 0.01%

Ireland 37 0.42%

Israel 61 0.70%

Italy 186 2.12%

Japan 491 5.60%

Jordan 4 0.05%

Kuwait 1 0.01%

Latvia 2 0.02%

Lebanon 1 0.01%

Libya 2 0.02%

Lithuania 15 0.17%

Luxembourg 3 0.03%

Macedonia 7 0.08%

Malaysia 1 0.01%

Mexico 101 1.15%

Moldova 2 0.02%

Mongolia 2 0.02%

Morocco 29 0.33%

Myanmar 6 0.07%

Nepal 1 0.01%

Netherlands 99 1.13%

New Caledonia 1 0.01%

New Zealand 22 0.25%

Niger 1 0.01%

Nigeria 3 0.03%

Norway 22 0.25%

Oman 1 0.01%

Pakistan 28 0.32%


Country Percentage

Panama 1 0.01%

Paraguay 1 0.01%

Peru 12 0.14%

Philippines 27 0.31%

Poland 59 0.67%

Portugal 32 0.37%

Qatar 2 0.02%

Romania 88 1.00%

Russia 46 0.52%

Saudi Arabia 31 0.35%

Serbia 1 0.01%

Singapore 29 0.33%

Slovakia 13 0.15%

Slovenia 1 0.01%

South Africa 3 0.03%

South Korea 132 1.51%

Spain 156 1.78%

Sri Lanka 2 0.02%

Swaziland 1 0.01%

Sweden 70 0.80%

Switzerland 84 0.96%

Taiwan 103 1.18%

Thailand 57 0.65%

Tunisia 9 0.10%

Turkey 85 0.97%

Ukraine 15 0.17%

United Arab Emirates 2 0.02%

United Kingdom 261 2.98%

United States 4071 46.45%

Uruguay 6 0.07%

Venezuela 16 0.18%

Vietnam 88 1.00%

ToTals 8765 100.0%



Full descriptions, goals and objectives available online at www.thelivermeeting.org/program

t H e L i v e r m e e t i N g ® 2 0 1 2 • b o S t o N , m A S S A c H u S e t t S , u S A

Meeting-at-a-Glance

thursday, November 82:00 – 8:00 pm Registration

friday, November 96:30 am – 7:30 pm Registration

7:55 am – 3:30 pm AASLD/ILTS Transplant course: Reaching the Summit: challenges and Obstacles in Liver Transplantation

8:00 – 11:00 am competency Training Workshop

8:00 am – 2:30 pm AASLD/ASge endoscopy course: common endoscopic challenges in Patients with Advanced Liver Disease

12:00 – 3:00 pm AASLD/nASPgHAn Pediatric Symposium: new Discoveries, controversies, and Differences in Pediatric viral Hepatitis

12:00 – 3:30 pm clinical Research Workshop: clinical epidemiology in Hepatology

3:30 – 7:40 pm Postgraduate course: Personalized Medicine and the Practice of Hepatology

Saturday, November 106:30 am – 7:30 pm Registration

8:00 am – 5:00 pm Postgraduate course: Personalized Medicine and the Practice of Hepatology

10:00 am – 1:00 pm Special Interest group Program: Training Paradigms in Liver Surgery: What expertise is Best for the Patient and How do We Develop it?

12:15 – 1:15 pm Meet-the-Professor Luncheons

2:00 – 7:30 pm Poster Session I (authors available 5:30 – 7:00 pm)

3:30 – 6:00 pm Transplant Surgery Workshop: Liver Transplantation for Alcoholic Hepatitis: A new Dawn or a Slippery Slope?

5:00 – 7:30 pm exhibits Open

5:00 – 7:30 pm Opening Reception

5:15 – 6:15 pm Business Meeting (members only)

Sunday, November 116:30 am – 6:00 pm Registration

6:30 – 8:00 am Professional Development Workshop

6:45 – 7:45 am early Morning Workshops

8:00 – 9:30 am Liver Transplant Plenary I

8:00 am – 12:00 pm Basic Research Workshop: Bile Acids and Metabolic Signaling

8:00 am – 1:30 pm Hepatology Associates course

8:00 am – 5:30 pm Poster Session II (authors available 12:30 – 2:00 pm)

9:30 – 10:00 am Thomas e. Starzl Transplant Surgery State-of-the-Art Lecture: controversies in Transplant for Hcc

9:30 am – 3:00 pm exhibits Open

10:30 am – 12:00 pm Liver Transplant Plenary II

12:00 – 12:30 pm Hans Popper Basic Science State-of-the-Art Lecture: Inflammatory control in Health and Disease

1:15 – 2:45 pm Parallel Sessions

2:00 – 2:30 pm President’s choice: Progress in Hepatitis B: A Journey from 1982 to 2012

New iN 2012

“Ideas come easier when I am exposed to other colleagues’ work and see the remaining issues to be answered.” — 2011 AtteNDee


RegisteR


Program subject to change. Please confirm schedule in October through the online Itinerary Planner, MyItinerary app, or onsite in the final printed Program.

t H e L i v e r m e e t i N g ® 2 0 1 2 • b o S t o N , m A S S A c H u S e t t S , u S A

2:45 – 3:00 pm Award Presentation (Distinguished clinician educator/Mentor)

2:45 – 6:45 pm AASLD/ncI Federal Focus: viral Hepatitis and Drug Discovery in Hcc

3:00 – 4:30 pm general Hepatology update


4:00 – 6:00 pm ABIM Maintenance of certification: Hepatology Medical Knowledge Module


4:45 – 6:45 pm Special Interest group Program: Heptatitis Delta virus: Advances in Our understanding of a globally Important Pathogen

4:45 – 6:45 pm Special Interest group Program: Management controversies in cystic Fibrosis Liver Disease

monday, November 126:30 am – 6:00 pm Registration


8:00 – 9:30 am Presidential Plenary I

8:00 am – 5:30 pm Poster Session III (authors available 12:30 – 2:00 pm)

9:30 – 10:00 am Award Presentations (Distinguished Service and Distinguished Achievement Awards)

9:30 am – 3:00 pm exhibits Open

10:00 – 10:30 am Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture: Mitochondria and Drug-induced Liver Injury

11:00 am – 12:30 pm Presidential Plenary II

11:00 am – 12:30 pm Advances for Practitioners

2:00 – 4:00 pm global Forum: Hcc geographical challenges


3:00 – 4:30 pm emerging Trends Symposium: coagulation and Anti-coagulation in Liver Disease

3:00 – 4:30 pm Late-breaking Abstracts

4:45 – 6:15 pm Hcv Symposium: Managing Difficult cases with Triple Therapy


4:45 – 6:45 pm Special Interest group Program: new concepts and Opportunities in Portal Hypertension

4:45 – 6:45 pm Special Interest group Program: Functional Roles of Purinergic Signaling in the Liver

tuesday, November 136:30 am – 12:30 pm Registration


7:00 am – 12:00 pm Poster Session Iv (authors available 10:30 am – 12:00 pm)

8:00 – 9:30 am Presidential Plenary III

9:30 – 10:00 am Hepatitis Debrief

10:00 – 10:30 am Leon Schiff State-of-the-Art Lecture: Alcoholic Hepatitis

10:45 am – 12:15 pm Parallel Sessions

New iN 2012

New iN 2012

New iN 2012

“He aprendido algunos conceptos y terapias para poner en práctica en mi país.” (I learned some new concepts and therapies to put into practice in my country.) — 2011 AtteNDee




Plenary, Parallel and Poster sessions

Plenary sessionsThree Presidential Plenary sessions and two Transplant Plenary sessions will be offered, each featuring six distinguished abstract presentations:

• sunday, november 11 8:00 – 9:30 am . . . . . . . . . . . . Liver transplant Plenary i 10:30 am – noon . . . . . . . . . . . Liver transplant Plenary ii

• monday, november 12 8:00 – 9:30 am . . . . . . . . . . . . Presidential Plenary i 11:00 am – 12:30 pm . . . . . . . . Presidential Plenary ii

• tuesday, november 13 8:00 – 9:30 am . . . . . . . . . . . . Presidential Plenary iii

A second home for The Liver Meeting®, as well as a host of other educational offerings is LiverLearning®: the official eLearning Portal of AASLD.

All attendees of The Liver Meeting® 2012 will receive a free one-year subscription to LiverLeaning®, providing access to:

Access all this and more at www.liverlearning.org

view presentations in liverlearning® while traveling through the

“talKs on the Go” app

• The Liver Meeting® 2012 – recorded sessions

• Transplant Hepatology certification Review course

• Hepatitis Single Topic conference—Hcv Direct Antiviral Agents (DAA): concepts, Development, and Optimal use

• The Liver Meeting® 2011—including the Hcv Symposium, President’s choice, State-of-the-Art Lectures, ePosters, and Postgraduate course

• Practice guidelines

Search by topics speakers, events, type of content, or content formats. LiverLearning® includes webcasts, ePosters, abstracts, video podcasts, and PowerPoint shared files.

http://www.talksonthego.com


RegisteR



Parallel sessionsOriginal and exciting advances in the study and practice of hepatology will be presented Sunday, november 11 through Tuesday, november 13. Parallel sessions will feature the following topics:

Poster sessionsThis exciting component of The Liver Meeting® extends learning beyond the oral sessions, giving you the opportunity to discuss the details of important research in the hepatology field individually with the authors. More than 1,000 basic science and clinical posters will be presented.

ePostersview posters presented at The Liver Meeting® onsite via the high definition flat screen ePoster kiosks. Browse abstracts by day, topic, author and keyword searches. Once you find the one you’re looking for, you can leave comments and questions for the presenting author. The ePoster viewing system is a free service for all attendees. You’ll be able to view posters on touch screen monitors at the Hynes convention center. If you can’t catch the ePosters onsite, they’ll be available after the meeting through LiverLearning®, the official eLearning portal of AASLD.

Late-breaking abstractsLate-breaking abstract sessions will take place on Monday, november 12

• acute Liver failure

• autoimmune and Cholestatic Liver disease

• Cirrhosis

• drug and alcohol toxicity

• Health services research

• Hepatic fibrosis

• Hepatic stellate Cell Biology

• Hepatitis B

• Hepatitis C

• Hepatobiliary neoplasia

• innate and adaptive immunity in Liver disease

• Liver transplantation

• mechanisms of Hepatic Carcinogenesis

• molecular and Cellular Biology of Bile formation

• nasH

• Pediatric Hepatology

• Portal Hypertension

• stem Cell Biology

• saturday, november 10 . . 2:00 – 7:30 pm

• sunday, november 11 . . . . 8:00 am – 5:30 pm

• monday, november 12 . . . 8:00 am – 5:30 pm

• tuesday, november 13 . . . 7:00 am – 12:00 pm




Course Descriptions

AASLD/iLtS transplant coursereaching the summit: Challenges and obstacles in Liver transplantation

friDAY, November 9: 7:55 Am – 3:30 Pm

courSe DirectorS: Kymberly D. Watt, MD; Marina Berenguer, MD; Julie K. Heimbach, MD

The pinnacle in liver transplantation is to help as many patients as feasible receive a lifesaving procedure with the best possible outcomes. This course will present an array of challenges in the current era of liver transplantation requiring focused energy in the future in order to advance our science.

competency training workshopfriDAY, November 9: 8:00 – 11:00 Am

orgANizerS: andrew P. Keaveny, MD and K. Gautham reddy, MD

This workshop is designed to assist Transplant Hepatology Program Directors, Program coordinators, clinical faculty and trainees in understanding the changes in training in Transplant Hepatology and to develop a better understanding of the next gMe accreditation system. The presenters will cover the background to the new combined fellowship pathway, a framework for competency based education, faculty development as well as perspectives from the American Board of Internal Medicine.

AASLD/ASge endoscopy courseCommon endoscopic Challenges in Patients with advanced Liver disease

friDAY, November 9: 8:00 Am – 2:30 Pm

courSe DirectorS: B. Joseph elmunzer, MD and William M. tierney, MD, fasGe

The purpose of the program is to instruct the audience, in lecture format, with the most evidence-based and up-to-date reviews of the professional literature regarding the optimal gastrointestinal endoscopic care of patients with liver disease and hepatobiliary disease, with an emphasis on clinical knowledge.

AASLD/NASPgHAN Pediatric Symposiumnew discoveries, Controversies, and differences in Pediatric Viral Hepatitis

friDAY, November 9: 12:00 – 3:00 Pm

courSe DirectorS: Daniel H. leung, MD and Philip rosenthal, MD

The purpose of this program is to review the pathophysiology, natural history, and risk factors of viral hepatitis while also specifically addressing candidacy for patient-tailored treatment and counsel.


RegisteR



Course Descriptions (continued)

clinical research workshopClinical epidemiology in Hepatology

friDAY, November 9: 12:00 – 3:30 Pm

courSe DirectorS: W. ray Kim, MD and James e. everhart, MD

The clinical Research Workshop is an educational event for clinical researchers in their early career (e.g., fellows/residents in training and junior faculty). The workshop will consist of a number of didactic talks on epidemiological study design and analyses followed by small group breakout sessions. In the breakout sessions, a faculty member will moderate and critique presentations by selected participants.

Postgraduate course Personalized medicine and the Practice of Hepatology

friDAY, November 9: 3:30 – 7:40 Pm SAturDAY, November 10: 8:00 Am – 5:00 Pm

courSe DirectorS: J. Gregory fitz, MD and andrew P. feranchak, MD

The purpose of this course is to introduce important advances in the genetic and molecular understanding of liver diseases into the clinical arena. The program will emphasize new findings that relate directly to understanding the mechanisms of liver injury and approaches to clinical management. There has been substantial progress in the science of hepatology that relates directly to common liver diseases, including cholestasis, viral hepatitis, nASH and the progression of fibrosis toward cirrhosis. Further, these insights have helped to direct newer therapeutic approaches to the treatment of these disorders and as well as management of the complications of cirrhosis. Based on these considerations, a series of expert lectures and case-related discussions will be utilized to address both common and complex issues in hepatology; and to ascertain progress toward personalized medical management based on risk. The educational emphasis will be placed on the evolving insights into the pathogenesis of liver injuries, and how these insights influence prevention and management now and in the future.

Special interest group Programtraining Paradigms in Liver surgery: What expertise is Best for the Patient and How do We develop it?DeveloPeD By tHe surGery anD liver transPlant siG

SAturDAY, November 10: 10:00 Am – 1:00 Pm

orgANizer: Jean emond, MD

This program will define a sphere of surgical expertise analogous to the advanced hepatology and review training pathways to achieve ideal preparation for surgeons who treat complex disorders of the liver.

New iN 2012

J. gregory fitz, md

andrew P. feranchak, md






meet-the-Professor Luncheons

SAturDAY, November 10: 12:15 – 1:15 Pm

Attendees of The Liver Meeting® have the opportunity to explore a wide variety of topics in hepatology in a small group setting. Topic moderators are experts in their particular specialty area for a given session.

transplant Surgery workshopLiver transplantation for alcoholic Hepatitis: a new dawn or a slippery slope?

SAturDAY, November 10: 3:30 – 6:00 Pm

orgANizerS: andrea DiMartini, MD and Michael r. lucey, MD

The overall goal of this activity is to increase awareness of the controversies surrounding the treatment of patients with alcoholic hepatitis and for the learner to understand the objective evidence supporting the various treatment options so they can make more informed treatments decisions.

Professional Development workshopan interactive guide to achieving the Leadership skills for academic and Professional growth and success

SuNDAY, November 11: 6:30 – 8:00 Am

orgANizerS: simona rossi, MD; Claudia Zein, MD; Gyongyi szabo, MD, PhD

DeveloPeD By tHe WoMen’s HealtH rePresentative CoMMittee

This interactive seminar led by Dr. Diane Mangrene, Director of the new International center for executive Leadership in Academics (IcLA) and Program Director of executive Leadership in Academic Medicine (eLAM) will provide a personal approach and guide to acquire the fundamental skills and knowledge necessary in achieving faculty and academic leadership.

• genetic understanding of cholestasis

• Hemochromatosis: genetic Testing and Screening

• case-based Strategy: Two children with cholestasis and normal γgT. Application of genetic testing, treatment and management strategies.

• Pharmacogenetics and Drug-induced Liver Injury

• current and new Therapies for Hepatitis B

• Hepatitis c: Future Therapies

• case-based Strategy: Decompensated Hcv cirrhosis in two adults. One adult with Hcv cirrhosis and further decompensation due to antiviral therapy and one adult with Hcv cirrhosis and HIv co-infection. Treatment and management strategies.

• non-invasive Markers of Liver Fibrosis

• genetics of Hepatic Fibrosis

• Anti-fibrotic Therapy: State-of-the-Art

• non-alcoholic Fatty Liver Disease: genetics and Future Treatments

• Hepatocellular carcinoma: Testing and Discovery of new Biomarkers

• case-based Strategy: An adult with compensated cirrhosis and 2 cm Hcc. Treatment and Management strategies.

• Tissue engineering and Liver cell Replacement

• Tailoring Immunosuppression Post-transplantation Based on genetics



RegisteR



early morning workshops

SuNDAY, November 11 6:45 – 7:45 Am moNDAY, November 12 6:45 – 7:45 Am tueSDAY, November 13 6:45 – 7:45 Am

These small group sessions provide participants with an opportunity to interact with two experts in a specialized area of liver disease or investigation. early Morning Workshops consist of two categories: Basic Research and clinical Management. The registration fee is per workshop, per day.

SuNDAY

basic early morning workshops

• nAFLD and Hepatocellular carcinoma

• Therapeutic Approaches to Fibrosis

• Molecular Basis of cholestasis – Management

• MicroRnAs in Liver Function

• Hcc: cellular Mechanisms of carcinogenesis

• iPS cells and Liver Regeneration

• Drug-induced Hepatotoxicity

clinical early morning workshops

• Management of Autoimmune Liver Disease: Transition from Pediatric to Adult

• nASH: Diagnosis and Management

• Hcc: Multidisciplinary Management

• use of TIPS in cirrhosis

• Post-transplant Metabolic Syndrome

• Transplant for Alcoholic Liver Disease

• Management of Drug Resistance in Hepatitis

moNDAY


• nASH: Mechanisms of cell Injury and Progression

• Hcv Molecular virology

• Pathogenesis of Alcoholic Liver Disease

• cholangiocyte Biology

• nodular Regenerative Hyperplasia

• Stellate and non-parenchymal cell Biology

• Innate Immunity and the Liver


• PSc and PBc: Mechanisms and Management

• cirrhotic cardiomyopathy

• Management of Portal Hypertension

• PnPLA3 variants and Other genetic Risks for nAFLD

• Hcv: Management of non-responders

• Withdrawal of Immunosuppressives Following Transplantation in children

• Recurrence of Liver Disease Post-transplant

tueSDAY


• Liver Disease in Pregnancy

• Autophagy

• Angiogenesis and cirrhosis

• Hypoxia and Liver Disease


• elastography in chronic Liver Disease

• Management of Hepatorenal Syndrome

• viral Reactivation Following Biological Therapies

• Drug-drug Interactions in Antiviral Therapy

• Fontan-associated Hepatic Fibrosis/cirrhosis

• Quality Assessment, Performance Improvement in Transplantation

• Trends in the Treatment of Acute Liver Failure

• Liver Transplantation for Porphyrias

• ethics and Humanities





basic research workshopBile acids and metabolic signaling

SuNDAY, November 11: 8:00 Am – 12:00 Pm

courSe DirectorS: Peter l. M. Jansen, MD, PhD and Willscott naugler, MD

This workshop will invite leaders in this field to synthesize recent developments in the regulation of bile acid homeostasis, and discuss new findings that tie bile acids to clinically relevant outcomes such as liver injury and metabolic signaling.

Hepatology Associates course

SuNDAY, November 11: 8:00 Am – 1:30 Pm

courSe Director: Dustin C. latimer, Pa-C

The purpose of this program is to enhance nP/PA provider education and understanding of current and future hepatology issues, and to keep providers abreast of disease concepts and management. As key concepts and treatments evolve, this program serves as an annual educational opportunity for providers and staff of hepatology and gI practices.

thomas e. Starzl transplant Surgery State-of-the-Art Lecture Controversies in transplant for HCCSuNDAY, November 11: 9:30 – 10:00 Am

PreSeNter: elizabeth Pomfret MD, PhD

Hepatocellular carcinoma (Hcc) occurs most commonly among people with cirrhosis and those suffering from viral hepatitis with or without cirrhosis. With the prevalence of hepatitis c and non-alcoholic steatohepatitis (nASH) increasing in the united States, it is expected that Hcc will remain problematic for the foreseeable future. Hcc may be successfully treated with surgical resection in a small percentage of patients however the tumor frequently presents with large or multifocal lesions or in a background of severe underlying cirrhosis precluding curative resection. This lecture will focus on the treatment options for Hcc with particular focus on the role of liver transplantation and the controversies that are associated with transplantation for Hcc. The current Hcc allocation policy does not adhere to the general principles for liver allocation adopted with the introduction of the MeLD score. namely, the current Hcc prioritization rules are categorical, purely waiting time based, are not based on any tumor biology variables, and do not take into account the degree of underlying liver disease. Prioritization and allocation proposals currently being considered by the OPTn/unOS Liver and Intestinal committee will be discussed along with post-transplant outcomes for patients with Hcc.

Hans Popper basic Science State-of-the-Art Lectureinflammatory Control in Health and diseaseSuNDAY, November 11: 12:00 – 12:30 Pm

PreSeNter: ruslan M. Medzhitov, PhD

Inflammatory control mechanisms will be discussed from a general biological perspective. A focus of discussion will be on the mechanisms underlying the potential of the inflammatory response to cause disease of homeostasis.



RegisteR



AASLD/Nci federal focusViral Hepatitis and drug discoverySuNDAY, November 11: 1:00 – 5:00 Pm

orgANizerS: lopa Mishra, MD; Gregory J. Gores, MD; arun J. sanyal, MD

viral hepatitis and Hepatocellular cancer are prominent global disorders. The faculty will address critical issues important to clinicians/health care providers who treat patients infected with viral Hepatitis and Hcc and liver damage. Leading clinician/scientists will discuss recent developments in the drug discovery in Hcc and present updates on the role of epigenetic modulation, genomics, and therapeutics targeting chemoprevention and treatment of hepatobiliary cancers and tumor initiating stem cells in the context of viral liver disease.

President’s choiceProgress in Hepatitis B: a Journey from 1982 to 2012SuNDAY, November 11: 2:00 – 2:30Pm

PreSeNter: anna s. f. lok, MD

This lecture will discuss the progress in prevention and management of hepatitis B from 1982 to 2012, including the success of vaccines and antiviral therapy and the yet unresolved issues from the perspective of the speaker who began her career in 1982 and who devoted most of the last 3 decades to hepatitis B research.

general Hepatology updateSuNDAY, November 11: 3:00 – 4:30 Pm

moDerAtorS: oren fix, MD and Cynthia levy, MD

This annual forum is intended to provide hepatologists the latest information regarding common clinical issues they may see in their practice. Issues including diagnostic strategies and approaches to management are reviewed to provide state-of-the-art guidelines particularly for diagnostic dilemmas. This year’s topics include: Hepatitis c; nutrition and Obese children; Alcohol

Abim maintenance of certification (moc)Hepatology medical Knowedge module

SuNDAY, November 11: 4:00 – 6:00 Pm

orgANizerS: steven K. Herrine, MD and Michael B. fallon, MD

The 25 question Hepatology Medical Knowledge Module will be reviewed using an audience response system. By the completion of the activity, participants should be able to successfully complete the ABIM Hepatology module for 10 points of MOc credit.

New iN 2012

New iN 2012





Special interest group ProgramHepatitis delta Virus: advances in our Understanding of a globally important PathogenDeveloPeD By tHe HePatitis B siG


orgANizerS: robert P. Perrillo, MD and robert Gish, MD

AASLD’s first ever Hepatitis B Special Interest groups (SIg) program at The Liver Meeting® focuses on the hepatitis delta virus (HDv), a fascinating and poorly treatable agent with serious clinical consequences. Speakers discuss disease prevalence in the uS and canada, new genomic test methods, and alternative drug treatments though the kinetics of HDv RnA and HBsAg decline.

Special interest group Programmanagement Controversies in Cystic fibrosis Liver disease DeveloPeD By tHe PeDiatriC liver DisorDers siG


orgANizerS: Michael r. narkewicz, MD and scott elisofon, MD

As the life expectancy for patients with cystic fibrosis liver disease (cFLD) increases, more patients are presenting with significant complications. This program will discuss the natural history and current understanding of cFLD, medical and surgical options, the objective standards for liver transplant listing, and whether transplantation improves outcomes.

Hyman J. zimmerman Hepatotoxicity State-of-the-Art Lecture mitochondria and drug-induced Liver injurymoNDAY, November 12: 10:00 – 10:30 Am

PreSeNter: neil Kaplowitz, MD

This lecture will provide an overview of the regulation of mitochondrial function and its role in the pathogenesis of hepatotoxicity.

Advances for PractitionersmoNDAY, mAY 12: 11:00 Am – 12:30 Pm

moDerAtor: Patrick s. Kamath, MD

This session will specifically focus on new advances in the management of patients with liver disease. Specifically, 3 major areas will be addressed. These include: alcoholic liver disease; chronic hepatitis B and chronic hepatitis c; and complications of cirrhosis.

New iN 2012



RegisteR



global forumHCC: geographical ChallengesmoNDAY, November 12: 2:00 – 4:00 Pm

orgANizerS: Guadalupe Garcia-tsao, MD and J. Gregory fitz, MD

This global forum focuses on the world-wide public health epidemic of hepatocellular carcinoma (Hcc). The aim of this program is to develop a discussion on this topic among the five major regions of the world, north America, europe, Asia, South America and Africa. The speakers will represent each region and discuss important issues and/or barriers regarding screening, diagnosis and management of Hcc as they pertain to each region. The discussion will address the most important public health problems regarding Hcc in each of these regions.

emerging trends SymposiumCoagulation and anti-coagulation in Liver diseasemoNDAY, mAY 12: 3:00 – 4:30 Pm

orgANizerS: stephen H. Caldwell, MD and a. K. Burroughs, frCP

Recent studies have caused a broad re-evaluation of the hemostatic system in cirrhosis. The aims of this symposium are to discuss new concepts in this field and the role of pro-coagulant factors in preventing or treating bleeding in cirrhosis, to discuss specific issues and therapeutic implications related to hyperfibrinolysis in liver disease, to review new concepts in the coagulation system in acute liver failure and to examine the question of anti-coagulation in cirrhotic portal vein thrombosis. The emphasis of the symposium will be clinical, but will include translational basic science research as a rationale for changing clinical practice.

Hcv Symposiummanaging difficult Cases with triple therapymoNDAY, mAY 12: 4:45 – 6:15 Pm

orgANizerS: Gary l. Davis, MD and raymond t. Chung, MD

The purpose of the program is to review nuances and developments of antiviral treatment in particularly difficult patient populations.

Special interest group Programnew Concepts and opportunities in Portal HypertensionDeveloPeD By tHe Portal HyPertension siG anD aCute on CHroniC liver failure siG

moNDAY, November 12: 4:45 – 6:45 Pm

orgANizerS: rajiv Jalan, MD; richard Moreau, MD; Juan Carlos Garcia-Pagan, MD; Jasmohan Bajaj, MD

This program explores novel mechanisms in portal hypertension and the impact of those mechanisms on treatment. There is a particular emphasis on special populations, single-center experiences, and multi-center database studies.





Special interest group Programfunctional roles of Purinergic signaling in the LiverDeveloPeD By tHe liver fiBrosis siG

moNDAY, November 12: 4:45 – 6:45 Pm

orgANizerS: Jonathan a. Dranoff, MD and simon C. robson, MD, PhD

There is increasing evidence that purinergic signaling has dramatic positive and inhibitory effects on cells involved in both innate and adaptive immunity, and on the chronic inflammatory cells that drive chronic inflammation and fibrosis. This program examines the potential for novel therapies based on this new evidence.

Hepatitis DebrieftueSDAY, November 13: 9:30 – 10:00 Am

PreSeNter: raymond Chung, MD

In the 18 months since the inception of the direct acting antiviral era, we have witnessed extraordinary progress in the development of increasingly effective, tolerable, and finite combination regimens for management of chronic hepatitis c. This session will review new data presented at the Liver Meeting® pertinent to combination treatments that add new DAAs to an interferon/ribavirin backbone, as well as all-oral, interferon sparing regimens. The session is designed to rapidly synthesize the new data so that they can be useful to the practitioner on a real-time basis.

Leon Schiff State-of-the-Art Lecturealcoholic HepatitistueSDAY, November 13: 10:00 – 10:30 Am

PreSeNter: Philippe Mathurin, MD, PhD


“Information gathered will be translated into better care of my patients.” — 2011 AtteNDee

“As an infectious disease specialist this was a great conference to attend.” — 2011 AtteNDee


RegisteR

Use promo code LM12ebContinuing Medical education (CMe)

The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation council for continuing Medical education (AccMe) to provide continuing medical education for physicians. AASLD designates these live activities for AMA PRA category 1 credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

maximum credit hours for each designated portion of the meeting are:

annual Meeting(State-of-the Art lectures; Plenary, Parallel and Poster sessions; President’s choice; general Hepatology update; global Forum; emerging Trends; Hepatitis Debrief; Hcv Symposium; Advances for Practitioners; Federal Focus; SIg Programming)

18 CMe credits

Postgraduate Course 12 CMe credits; 7.25 contact hours*

Basic research Workshop 4 CMe credits

Hepatology associates Course 5.5 CMe credits; 3.75 contact hours*

aaslD/ilts transplant Course 7.5 CMe credits**; 4.5 contact hours*

aaslD/asGe endoscopy Course 6.5 CMe credits***

transplant surgery Workshop 3.0 CMe credits

aaslD/nasPGHan Pediatric symposium 3.0 CMe credits***

* SAtiSfActorY comPLetioN: Participants must have paid tuition fee and completed an online Attendance/evaluation form in order to receive a continuing education certificate. Participants not fulfilling these requirements will not receive a certificate. Failure to complete the online Attendance/ evaluation form will result in forfeiture of credit for the entire conference. no exceptions will be made. Partial credit of individual sessions is not available. certificates are available immediately after completing the online form.

The Institute for Advancement of Human Behavior is accredited as a provider of continuing nursing education by the American nurses credentialing center’s commission on Accreditation. This course is co-provided by IAHB and AASLD. Maximum 15.5 contact hours.

Only the following sessions will award nurse continuing education contact hours, as noted:

• AASLD/ILTS Transplant course – 4.5 contact hours • Postgraduate course – 7.25 contact hours • Hepatology Associates course – 3.75 contact hours

** This activity has been planned and implemented in accordance with the essential Areas and Policies of the Accreditation council for continuing Medical education through the joint sponsorship of the American Association for the Study of Liver Diseases (AASLD), and the International Liver Transplantation Society (ILTS). AASLD is accredited by the AccMe to provide continuing medical education for physicians.

*** co-SPoNSoreD ActivitieS: The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation council for continuing Medical education to provide continuing medical education for physicians.

To receive cMe credits or a certificate of Attendance, attendees are encouraged to use the online evaluation system at computer terminals located at the meeting or online at the conclusion of the meeting.

Please note: cMe will not be provided for all educational sessions at The Liver Meeting® 2012. AccMe guidelines prohibit cMe providers from providing credit for programs that include presentations by employees of commercial interest that relate to the business lines and products of its employer.




exhibit Hall

More than 60 companies present in the exhibit hall will give you access to the latest products, services, and technology relative to hepatology. From the Opening Reception to coffee breaks each day, this important component of the meeting extends networking beyond the sessions.

Saturday, November 105:00 pm – 7:30 pm . . . . . . exhibits open

5:00 pm – 7:30 pm . . . . . . opening reception

Sunday, November 11 9:30 am – 3:00 pm . . . . . . exhibits open

10:00 am – 10:30 am . . . . Coffee Break

1:30 pm – 2:00 pm . . . . . . snack Break

monday, November 12 9:30 am – 3:00 pm . . . . . . exhibits open

10:30 am – 11:00 am . . . . . Coffee Break

1:30 pm – 2:00 pm . . . . . . snack Break

• abbott• acariaHealth• alpha-1 foundation • american Liver foundation• asian Pacific association for the

study of the Liver (aPasL)• astellas Pharma Us• Bayer HealthCare• Bayer HealthCare/onyx

Pharmaceuticals• Bionutrigen Co. Ltd.• BioPlus specialty Pharmacy• BioPredictive fibrotest• Boehringer ingelheim

Pharmaceuticals, inc.• Bristol-myers squibb• Cholangiocarcinoma foundation, the• Chronic Liver disease foundation• Clinical Care options• Cochrane Hepato-Biliary group, the• Corgenix, inc.• Cti Clinical trial and

Consulting services• Curascript specialty Pharmacy

• CVs/Caremark specialty Pharmacy• duke Clinical research institute• echosens• elsevier inc.• european association for the

study of the Liver (easL)• eXHiBitCHeK• gambro inc.• gastroenterology & endoscopy news• gastroenterology & Hepatology• genentech• gilead sciences, inc.• gore & associates, inc.• Hra Healthcare research & analytics• ikaria• innogenetics nV• international Liver transplantation

society (iLts)• Janssen therapeutics• LabCorp• medfusion/ascend• merck & Co.• national institute on alcohol

abuse and alcoholism (niaaa)

• novartis Pharmaceuticals Corporation

• orasure technologies• otsuka• oxford University Press• Pfizer inc.• PharmaHealth specialty Pharmacy• PhoenixBio• Pra• Projects in Knowledge, inc.• salix Pharmaceuticals• sC Liver research Consortium• siemens Healthcare Usa• supersonic imagine• University of Pittsburgh

division of gastroenterology, Hepatology & nutrition

• Us Bioservices specialty Pharmacy• Vertex Pharmaceuticals• Visualsonics• Wako diagnostics• Walgreens specialty Pharmacy• Wiley-Blackwell• World Hepatitis alliance

exhibitors More info

(as of JULY 16, 2012)

http://www.aasld.org/lm2012/2012/exhibits/Pages/currentexhibitors.aspx


RegisteR

Use promo code LM12ebGeneral information

Disclosure PolicyIt is the policy of the American Association for the Study of Liver Diseases (AASLD) to ensure balance, independence, objectivity, and scientific rigor in all its individually or jointly sponsored educational programs. Individuals in a position to control the content of an AASLD-sponsored activity (program planners, course directors, speakers, etc.) are expected to disclose all relevant financial relationships during the past 12 months. AASLD will identify and resolve all conflicts of interest prior to program implementation.

use of AASLD Scientific Program contentInformation presented during The Liver Meeting® is the property of AASLD and the presenter. Information may not be recorded, photographed, copied, photocopied, transferred to electronic format, reproduced, or distributed without the written permission of AASLD and the presenter. Any use of the program content, which includes, but is not limited to, oral presentations, audiovisual materials used by speakers, and program handouts, without the written consent of AASLD is prohibited.

Abstract embargo PolicyAccepted abstracts are made available to the public on the AASLD website and are published in the October supplement of Hepatology. Information contained in those abstracts may not be released until the abstracts appear on the AASLD website. Academic institutions, private organizations, and companies with products whose values may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an abstract on the AASLD website. However, information beyond that contained in the abstract, e.g., discussion of the abstract done as part of a scientific presentation or presentation of additional or new information that will be available at the time of the meeting is embargoed from release to the general public until the first day of The Liver Meeting®.

Information released prior to this day is a violation of the AASLD Abstract embargo Policy and the abstract is subject to withdrawal from The Liver Meeting® program. Authors are responsible for notifying financial and other sponsors about this policy.

AASLD may allow for exceptions, on a case-by-case basis, to the Abstract embargo Policy for compelled disclosures mandated by federal securities laws. However, AASLD requires the company President, general counsel, or other appropriate official of a company seeking such an exception to attest in writing to the specific facts in support of the request, including exactly how the securities laws are implicated, with statutory citation(s). general statements of the need to comply with the law will not be considered sufficient. Requests for an exception must be sent to the AASLD executive Director ([email protected]). AASLD requires a minimum of five (5) days from receipt of the request to evaluate the request. In granting an exception, the AASLD requires the company to state in their public disclosure that the complete and final results will be presented at The Liver Meeting®. The AASLD will also require the inclusion of unreleased and unique data in such a presentation at The Liver Meeting®.

Public release of a journal article relevant to the abstract will be considered an exception to the embargo Policy if at the time of the abstract submission deadline, the decision concerning the manuscript had not been revealed to the authors.

Limited LicenseThe Liver Meeting® is protected by copyright, trademark, and/or other applicable laws. Any use of The Liver Meeting®, including recordings and the development of derivative works, is prohibited. The name, logo and acronym of the American Association for the Study of Liver Diseases and The Liver Meeting® are the exclusive property of and are trademarked by AASLD. They may not be used in any way, for any purpose, or at any time (including but not limited to announcements, invitations, emails, Web publications, etc.) without the express written permission of AASLD.

view complete guidelines on the AASLD website.


http://www.aasld.org/aboutus/Pages/copyandtrademark.aspx

Perhaps Boston can be best described as a welcome contradiction: Hip alongside historic. Skyscrapers surround parks. gourmet meets pizza. Just as the city pays homage

to every period of America’s timeline, it also serves as all things to all people. Boston is a wonderful blend of stylish sophistication and historic new england charm. You can easily uncover the city’s past while enjoying its distinctively modern edge.

Boston is at its most beautiful in the fall. As the leaves turn, Boston’s parks put on an unforgettable show, complementing the historic architecture. A walk along the city’s Freedom Trail now doubles as a foliage tour. It’s a great time to visit Boston’s Faneuil Hall Marketplace, as the crowds thin out, but the weather is still pleasant.

RegisteR ReseRve a Hotel Make tRavel aRRangeMents


register online

Boston Highlights

oNLiNe: Register at www.thelivermeeting.org.

oNSite: Onsite registration will be located in Hall A at the Hynes convention center and will be open during the following dates and times:

• Thursday, november 8 2:00 pm – 8:00 pm

• Friday, november 9 6:30 am – 7:30 pm

• Saturday, november 10 6:30 am – 7:30 pm

• Sunday, november 11 6:30 am – 6:00 pm

• Monday, november 12 6:30 am – 6:00 pm

• Tuesday, november 13 6:30 am – 12:30 pm

QueStioNS?

cuStomer Service ceNter: 508-743-8541 (toll-free 866-672-3797)

emAiL: [email protected].

Make your hotel reservations when you register for The Liver Meeting®. All hotel reservations must be made through onPeak, AASLD’s housing provider. A list of hotels and a hotel map can be found on page 24 of this brochure.

Make your reservation:

oNLiNe: Register at www.thelivermeeting.org/attendees

PHoNe (u.S.): call 888-254-0939

PHoNe (iNterNAtioNAL): call 1-312-527-7300

If you are traveling from outside the u.S., you may require a visa for entry.

click here for more information:

• On international travel,

• To determine your immigration requirements for entry into the u.S. and,

• To request a letter of invitation.

http://www.aasld.org/lm2012/2012/attendees/Pages/international.aspx


RegisteR

Use promo code LM12ebregistration fees

ANNuAL meetiNg (state-of-the art lectures; Plenary, Parallel and Poster sessions; President’s Choice; general Hepatology Update; global forum; Hepatitis debrief; HCV symposium; advances for Practitioners; federal focus; sig Programming; the exhibit Hall; and access to content in LiverLearning)

Saturday–tuesday, Nov 10–13 ADvANce reguLAr1. Member $90 $1902. corporate Affiliate Member $90 $1903. Trainee Member nc $1054. Hepatology Associate Member $90 $1905. non-Member $455 $5556. Trainee non-Member $195 $2957. Hepatology Associate non-Member $195 $2958. Student $90 $190

cLiNicAL reSeArcH worKSHoPClinical Epidemiology in Liver Diseases friday, November 9 ADvANce reguLAr1. Member $50 $602. corporate Affiliate Member $50 $603. Trainee Member $35 $454. Hepatology Associate Member $35 $455. non-Member $55 $656. Trainee non-Member $40 $507. Hepatology Associate non-Member $40 $508. Student $35 $45

PoStgrADuAte courSePersonalized Medicine and the Practice of Hepatologyfriday–Saturday, November 9–10 ADvANce reguLAr1. Member $440 $5402. corporate Affiliate Member $440 $5403. Trainee Member $180 $2804. Hepatology Associate Member $180 $2805. non-Member $660 $7606. Trainee non-Member $260 $3607. Hepatology Associate non-Member $260 $3608. Student $180 $280

meet-tHe-ProfeSSor LuNcHeoNS Click hereSaturday, November 10 ADvANce reguLAr1. Member $50 $602. non-Member $50 $60

trANSPLANt SurgerY worKSHoPLiver Transplantation for Alcoholic Hepatitis: A New Dawn or a Slippery Slope?Saturday, November 10 ADvANce reguLAr1. Member $85 $1352. corporate Affiliate Member $85 $1353. Trainee Member $70 $1204. Hepatology Associate Member $70 $1205. non-Member 105 $1556. Trainee non-Member $75 $1257. Hepatology Associate non-Member $75 $1258. Student $70 $120

eArLY morNiNg worKSHoPS Click hereSunday–tuesday, Nov 11–13 ADvANce reguLAr1. Member $25 $352. non-Member $45 $553. Student $25 $35

mAiNteNANce of certificAtioNSunday, November 11 ADvANce reguLAr1. Member $65 $752. non-Member $75 $85

bASic reSeArcH worKSHoPBile Acids and Metabolic SignalingSunday, November 11 ADvANce reguLAr1. Member $85 $1352. corporate Affiliate Member $85 $1353. Trainee Member $70 $1204. Hepatology Associate Member $70 $1205. non-Member $105 $1556. Trainee non-Member $75 $1257. Hepatology Associate non-Member $75 $1258. Student $70 $120

HePAtoLogY ASSociAteS courSe Sunday, November 11 ADvANce reguLAr1. Member $85 $1352. non-Member $160 $2103. Student $85 $135

ProfeSSioNAL DeveLoPmeNt worKSHoPSunday, November 11 ADvANce reguLAr1. Member $30 $402. non-Member $50 $603. Student $30 $40

AASLD/iLtS trANSPLANt courSeReaching the Summit: Challenges and Obstacles in Liver Transplantationfriday, November 9 ADvANce reguLAr1. Member $180 $2302. corporate Affiliate Member $180 $2303. Trainee Member $105 $1554. Hepatology Associate Member $105 $1555. non-Member $265 $3156. Trainee non-Member $115 $1657. Hepatology Associate non-Member $115 $1658. Student $105 $155

AASLD/NASPgHAN PeDiAtric SYmPoSiumNew Discoveries, Controversies, and Differences in Pediatric Viral Hepatitisfriday, November 9 ADvANce reguLAr1. Member $155 $2052. corporate Affiliate Member $155 $2053. Trainee Member $75 $1254. Hepatology Associate Member $75 $1255. non-Member $260 $3106. Trainee non-Member $95 $1457. Hepatology Associate non-Member $95 $1458. Student $75 $125

AASLD/ASge eNDoScoPY courSeCommon Endoscopic Challenges in Patients with Advanced Liver Diseasefriday, November 9 ADvANce reguLAr1. Member $245 $2952. corporate Affiliate Member $245 $2953. Trainee Member $75 $1254. Hepatology Associate Member $75 $1254. non-Member $380 $4306. Trainee non-Member $95 $1457. Hepatology Associate non-Member $95 $1453. Student $75 $125

AASLD’s official photographer will be taking pictures throughout The Liver Meeting® 2012. By registering to attend The Liver Meeting® 2012, you consent to the use of any of these photos in which you may appear in future AASLD materials.


Securing an exclusive rate agreement with the official event hotelsContinually monitoring prices offered on other travel websitesNegotiating further discounted rates at event hotels when necessaryAutomatically reconfirming existing bookings with the lower rates

If you find a lower rate, please contact us.

Within the competitive climate of the travel industry, our priority is to serve you best and provide the lowest hotel rates available for your stay by:

GroupBooking

Any group requesting 20 or more rooms must email their request to [email protected]. A sub-block contract will be required prior to confirming rooms.

6

8

9

12

1514

13

7

11

43

16

2

5

101

Map used to indicate approximate locations only.

Official Hotels & Rates

Map

1. Sheraton Boston 39 Dalton St - Headquarter Hotel Single/Double: $289 Connected

2. Colonnade Boston 120 Huntington Ave Single/Double: $272 1 block 3. Copley Square Hotel 47 Huntington Ave Single/Double: $312 2 blocks 4. Courtyard Boston Tremont 275 Tremont St Single: $242, Double: $262 1.6 miles 5. Doubletree by Hilton Downtown 821 Washington St Single/Double: $265 1.6 miles 6. Fairmont Copley Plaza 138 St James Ave Single/Double: $319 4 blocks 7. Hilton Boston Back Bay 40 Dalton St Single/Double: $290 .5 block 8. Hyatt Regency Boston One Avenue de Lafayette Single/Double: $289 1 mile

9. Langham Hotel Boston 250 Franklin St Single/Double: $285 2 miles 10. Marriott Copley Place 110 Huntington Ave Single/Double: $302 1.5 block 11. MidTown Hotel 220 Huntington Avenue Single/Double: $169 .5 mile 12. Omni Parker House 60 School St Single/Double: $275 1.4 miles 13. Park Plaza Hotel & Towers 64 Arlingston St Single/Double: $225 6 blocks 14. Revere Hotel Boston Common 200 Stuart St Single/Double: $269 1.3 miles 15. W Boston 100 Stuart St Single/Double: $329 1 mile 16. Westin Copley Place 10 Huntington Ave Single/Double: $309 3 blocks

3 Ways to Book

Rates do not include current tax of 14.45% or applicable surcharges, subject to change.

www.thelivermeeting.org

(888) 254 0939 US Toll-free(312) 527 7300 Local

[email protected]

Hotel information [hyperlink marker]



RegisteR

Use promo code LM12ebadditional registration information

register by october 12: Save money and Secure HousingBy making registration and housing arrangements in advance, you will save money, ensure a reservation at the hotel of your choice, and secure your place in popular ticketed sessions. Save $100 by registering for the AASLD 63rd Annual Meeting on or before October 12! Save $100 by registering for the Postgraduate course on or before October 12!

ticketed SessionsMost of the sessions at The Liver Meeting® are included in your Annual Meeting registration fee; however, some sessions require an additional registration fee. The ticket icon denotes these sessions.

The cost of each session is listed on page 23. Register early, ticketed sessions sell out quickly.

registration confirmationconfirmation of your registration arrangements will be sent within 24 hours of receipt. If you do not receive a confirmation within two business days, please contact AASLD registration at 508-743-8541 or [email protected].

itinerary PlannerPlan your experience at The Liver Meeting® before you arrive in Boston with our online Abstract viewer and Itinerary Planner. Planning your schedule in advance will ensure you don’t miss a thing at The Liver Meeting®. Search by titles, category, speaker, session type, date and time to find sessions and posters of interest to you.

visa requirements/ visa waiver ProgramParticipants from outside the u.S. may need to apply for a visa at the American embassy, consulate or other visa-issuing office in their country of origin. To obtain a visa, you will need a letter of invitation, a valid passport, a photo ID and a completed DS-156 form (non-immigrant visa application form). To request an invitation letter, click here.

International travelers seeking to travel to the u.S. under the visa Waiver Program are now subject to enhanced security requirements. All eligible travelers who wish to travel under this program must apply for authorization using the electronic System for Travel Authorization (eSTA) website, https://esta.cbp.dhs.gov/.

To learn more about these requirements, click here or go to the u.S. Department of State website at www.travel.state.gov.

meeting cancellations and refundsA written cancellation and refund request is required for all cancellations. Requests received on or before October 19 will be eligible for a full refund of registration fees.* Requests received on October 20 through november 7 will be subject to a $50 administrative fee. cancellations received on or after november 8, 2012 will not be refunded. Fees will not be refunded for no-shows.

*�Unless�your�selection�was�filled�to�capacity,�there�are�no�refunds�for�the�Meet-the-Professor�Luncheons�or�Early�Morning�Workshops.

Hotel reservations and cancellationsYou will receive confirmation of your housing within 72 hours of receipt. Individual reservations must be cancelled at least 72 hours prior to the day of arrival in order to avoid loss of deposit. For groups or Affiliates holding 10 or more rooms the deposit is nonrefunDaBle and nontransferaBle after September 10, 2012.


1001 north fairfax street, suite 400alexandria, Virginia 22314

Phone: 703-299-9766email: [email protected]




American Association for the Study of Liver Disease (AASLD): The Liver Meeting

Documents

Transcript of American Association for the Study of Liver Disease (AASLD): The Liver Meeting